Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Episode 13 October 27, 2021 00:50:12
Episode 13:  Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Oct 27 2021 | 00:50:12

/

Show Notes

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.

Other Episodes

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 31

June 20, 2023 00:44:32
Episode Cover

Episode 31: Pam Cusick, SVP, Rare Patient Voice

"What can I contribute that my doctor can't contribute? And that's a real 'a-ha' moment when we share with them how they're the experts...

Listen

Episode 57

July 22, 2025 00:44:53
Episode Cover

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host...

Listen